{"name":"Sufentanyl","slug":"sufentanyl","kind":"substance","abbreviations":[],"systematic":null,"aliases":["Chronogesic","Sufentanilum","Zalviso","R-30730","Sufentanilo","N-(4-(Methoxymethyl)-1-(2-(2-thienyl)ethyl)-4-piperidyl)propionanilide","N-(4-(Methoxymethyl)-1-(2-(2-thienyl)ethyl)-4-piperidinyl)-N-phenylpropanamide","Ids-ns-001","R 30730","Sulfentanil"],"brands":[],"scraped":true,"has_structure":true,"cid":41693,"classes":[{"name":"anaesthetic","href":"/class/anaesthetic"},{"name":"opioid","href":"/class/opioid"}],"families":[{"name":"aniline","href":"/substituted/aniline"}],"physical":[{"label":"Molecular mass","value":"386.60 g/mol","copyable":false},{"label":"Appearance","value":"Crystals from petroleum ether","copyable":false},{"label":"Melting point","value":"136.3","copyable":false},{"label":"Solubility","value":"Soluble","copyable":false},{"label":"Predicted LogP","value":"4","copyable":false}],"identifiers":[{"label":"Molecular formula","value":"C<sub>22</sub>H<sub>30</sub>N<sub>2</sub>O<sub>2</sub>S","copyable":true},{"label":"IUPAC name","value":"N-[4-(methoxymethyl)-1-(2-thiophen-2-ylethyl)piperidin-4-yl]-N-phenylpropanamide","copyable":true},{"label":"SMILES","value":"CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCC3=CC=CS3)COC","copyable":true},{"label":"InChI","value":"InChI=1S/C22H30N2O2S/c1-3-21(25)24(19-8-5-4-6-9-19)22(18-26-2)12-15-23(16-13-22)14-11-20-10-7-17-27-20/h4-10,17H,3,11-16,18H2,1-2H3","copyable":true},{"label":"InChIKey","value":"GGCSSNBKKAUURC-UHFFFAOYSA-N","copyable":true},{"label":"CAS number","value":"56030-54-7","copyable":true},{"label":"UNII","value":"AFE2YW0IIZ","copyable":true},{"label":"PubChem CID","value":"41693","copyable":true}],"pharmacokinetics":[{"label":"Elimination half-life","value":"162 minutes","copyable":false},{"label":"Duration of action","value":"30–60 min<a href=\"#cite_note-3\"><sup>[3]</sup></a>","copyable":false},{"label":"Routes of administration","value":"Intravenous therapy (IV), intramuscular injection (IM), subcutaneous injection (SQ), epidural, intrathecal, sublingual","copyable":false}],"toxicity":[{"kind":"LD50","organisms":[["Dog",[{"kind":"LD50","organism":"Dog","route":"iv","dose":"10.1-19.5"}]],["Guinea",[{"kind":"LD50","organism":"Guinea","route":"pig iv","dose":"11.8-13"}]],["Mouse",[{"kind":"LD50","organism":"Mouse","route":"iv","dose":"16.8-18.7"},{"kind":"LD50","organism":"mouse","route":"parenteral-intravenous","dose":"18.7 mg/kg"}]],["Rat",[{"kind":"LD50","organism":"Rat","route":"iv","dose":"9.3-12.5"}]]]}],"dosing":null,"salts":[{"title":"Sufentanyl citrate","name":"citrate","slug":"sufentanyl_citrate","drawn":true},{"title":"Sufentanyl hydrochloride","name":"hydrochloride","slug":"sufentanyl_hydrochloride","drawn":true}],"esters":[],"chirality":"achiral","stereo_type":null,"optical_activity":null,"stereoisomers":[],"lipinski":{"passes":true,"violations":0},"reagents":[],"atc":[{"code":"N","description":"Nervous system"},{"code":"N01","description":"Anesthetics"},{"code":"N01A","description":"Anesthetics, general"},{"code":"N01AH","description":"Opioid anesthetics"},{"code":"N01AH03","description":""},{"code":"N01AH03","description":"Sufentanil"}],"mesh":[{"name":"Analgesics, Opioid","id":"M0001068"},{"name":"Adjuvants, Anesthesia","id":"M0001144"},{"name":"Narcotics","id":"M0014481"},{"name":"Anesthetics, Intravenous","id":"M0027999"}],"actives":[],"prodrugs":[],"codrug":false,"interactions":[],"mechanism":"Sufentanil is a synthetic, potent opioid with highly selective binding to μ-opioid receptors. These receptors are widely distributed in the human brain, spinal cord, and other tissues,.  In general, opioids decrease cAMP (affecting neural signaling pathways), decrease neurotransmitter release, and cause membrane hyperpolarization, all of which contribute to the relief of painful symptoms.  Opiate receptors are coupled with G-protein receptors and function as both positive and negative regulators of synaptic neural transmission via G-proteins that activate effector proteins. Binding of the opiate receptor leads to the exchange of GTP for GDP on the G-protein complex. As the effector system is adenylate cyclase and cAMP, located at the inner surface of the plasma membrane, opioids decrease intracellular cAMP by inhibiting adenylate cyclase. The release of nociceptive neurotransmitters such as substance P, GABA, dopamine, acetylcholine, and noradrenaline is then inhibited.   Opioids close N-type voltage-operated calcium channels (OP2-receptor agonist), also preventing neurotransmitter release.  Sufentanil and other opioids open calcium-dependent inwardly rectifying potassium channels, resulting in hyperpolarization and reduced neuronal excitability,.","side_effects":{"drug_id":41693,"drug_name":"sufentanil","url":"https://sideeffects.embl.de/drugs/41693/pt","atc_codes":["N01AH03"],"side_effects":[{"name":"Pruritus","cui":"C0033774"},{"name":"Hypotension","cui":"C0020649"},{"name":"Hypertension","cui":"C0020538"},{"name":"Muscle rigidity","cui":"C0026837"},{"name":"Bradycardia","cui":"C0428977"},{"name":"Dizziness","cui":"C0012833"},{"name":"Chills","cui":"C0085593"},{"name":"Euphoric mood","cui":"C0235146"},{"name":"Body temperature increased","cui":"C0015967"},{"name":"Miosis","cui":"C0026205"},{"name":"Urinary incontinence","cui":"C0042024"},{"name":"Injection site pain","cui":"C0151828"},{"name":"Anaphylactic shock","cui":"C0002792"},{"name":"Apnoea","cui":"C0003578"},{"name":"Arrhythmia","cui":"C0003811"},{"name":"Bronchospasm","cui":"C0006266"},{"name":"Confusional state","cui":"C0009676"},{"name":"Feeling abnormal","cui":"C1443060"},{"name":"Dermatitis","cui":"C0011603"},{"name":"Rash","cui":"C0015230"},{"name":"Headache","cui":"C0018681"},{"name":"Cardiac arrest","cui":"C0018790"},{"name":"Hypersensitivity","cui":"C0020517"},{"name":"Laryngospasm","cui":"C0023066"},{"name":"Nausea","cui":"C0027497"},{"name":"Tachycardia","cui":"C0039231"},{"name":"Erythema","cui":"C0041834"},{"name":"Urethral disorder","cui":"C0041969"},{"name":"Urinary tract disorder","cui":"C0042075"},{"name":"Vomiting","cui":"C0042963"},{"name":"Urinary retention","cui":"C0080274"},{"name":"Respiratory depression","cui":"C0235063"},{"name":"Pulmonary function test decreased","cui":"C0855775"},{"name":"Hypopnoea","cui":"C0235546"},{"name":"Somnolence","cui":"C2830004"}],"indications":[{"name":"Pain","cui":"C0030193"}]},"effects":{"groups":[["Physical Effects",["Constipation","Cough suppression","Difficulty urinating","Itchiness","Nausea","Pain relief","Pupil constriction","Respiratory depression","Sedation","Stomach cramp"]],["Cognitive Effects",["Anxiety suppression","Cognitive euphoria","Compulsive redosing","Increased music appreciation","Thought deceleration"]],["Visual Effects",["Double vision"]]]},"usernotes":[],"erowid":[],"reddit":[],"legal":[{"jurisdiction":"Australia","status":"Schedule 8","act":null,"refs":[]},{"jurisdiction":"Brazil","status":"A1","act":null,"refs":[4]},{"jurisdiction":"Canada","status":"Schedule I","act":null,"refs":[]},{"jurisdiction":"Germany","status":"Anlage III","act":"Betäubungsmittelgesetz (BtMG)","refs":[]},{"jurisdiction":"United Kingdom","status":"Class A","act":"Misuse of Drugs Act 1971","refs":[]},{"jurisdiction":"United States","status":"Schedule II","act":"Controlled Substances Act","refs":[5,6]},{"jurisdiction":"European Union","status":"Prescription only","act":null,"refs":[7]},{"jurisdiction":"Other","status":"SE: Förteckning II In general: ℞ (Prescription only)","act":null,"refs":[8]}],"members":[],"part_of":[],"links":[{"source":"Wikipedia","url":"https://en.wikipedia.org/wiki/Sufentanil"},{"source":"PubChem","url":"https://pubchem.ncbi.nlm.nih.gov/compound/41693"},{"source":"Wikidata","url":"https://www.wikidata.org/wiki/Q417915"},{"source":"DrugBank","url":"https://go.drugbank.com/drugs/DB00708"},{"source":"ChEMBL","url":"https://www.ebi.ac.uk/chembl/explore/compound/CHEMBL658"},{"source":"ChEBI","url":"https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI%3A9316"},{"source":"Common Chemistry","url":"https://commonchemistry.cas.org/detail?cas_rn=56030-54-7"},{"source":"HMDB","url":"https://hmdb.ca/metabolites/HMDB0014846"},{"source":"KEGG","url":"https://www.kegg.jp/entry/C08022"},{"source":"EPA DSSTox","url":"https://comptox.epa.gov/dashboard/chemical/details/DTXSID6023604"},{"source":"Effect Index","url":"https://www.effectindex.com/search?q=Sufentanyl"},{"source":"UNII","url":"https://gsrs.ncats.nih.gov/ginas/app/ui/substances/AFE2YW0IIZ"},{"source":"SIDER","url":"https://sideeffects.embl.de/drugs/41693/pt"}],"references":["National Center for Biotechnology Information. PubChem Compound Summary for CID 41693, Sufentanyl. Accessed November 20, 2026. <a href=https://pubchem.ncbi.nlm.nih.gov/compound/41693>https://pubchem.ncbi.nlm.nih.gov/compound/41693</a>","U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. Sufentanyl. UNII: AFE2YW0IIZ. Global Substance Registration System. Accessed November 20, 2026. <a href=https://gsrs.ncats.nih.gov/ginas/app/beta/substances/AFE2YW0IIZ>https://gsrs.ncats.nih.gov/ginas/app/beta/substances/AFE2YW0IIZ</a>","Shaw LM. The clinical toxicology laboratory : contemporary practice of poisoning evaluation. AACC Press. 2001. <a href='https://books.google.com/books?id=pXvFGqz44pYC&amp;pg=PA89'>https://books.google.com/books?id=pXvFGqz44pYC&amp;pg=PA89</a>","RDC Nº 784 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial. Diário Oficial da União. 31 March 2023. <a href='https://www.in.gov.br/en/web/dou/-/resolucao-rdc-n-784-de-31-de-marco-de-2023-474904992'>https://www.in.gov.br/en/web/dou/-/resolucao-rdc-n-784-de-31-de-marco-de-2023-474904992</a>","Sufenta- sufentanil citrate solution. DailyMed. 2 July 2008. <a href='https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=39dc3695-dbf2-4783-b1bf-97237593f1c0'>https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=39dc3695-dbf2-4783-b1bf-97237593f1c0</a>","Dsuvia- sufentanil tablet. DailyMed. 18 December 2023. <a href='https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=8b580f3d-e3b5-4086-b093-87a980631147'>https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=8b580f3d-e3b5-4086-b093-87a980631147</a>","Dzuveo EPAR. European Medicines Agency (EMA). 25 June 2018. <a href='https://www.ema.europa.eu/en/medicines/human/EPAR/dzuveo'>https://www.ema.europa.eu/en/medicines/human/EPAR/dzuveo</a>","Dzuveo, Resoriblett, sublingual 30 mikrog. FASS. 8 February 2024. <a href='https://fass.se/health/product/19910906000029/fass-text'>https://fass.se/health/product/19910906000029/fass-text</a>"],"sources":[{"source":"dosing","status":"missing","fetched_at":"2026-11-20 09:15:01","note":"no dosing statistics"},{"source":"drugspro","status":"missing","fetched_at":"2026-11-20 09:14:57","note":"no DrugsPRO reagent data"},{"source":"erowid","status":"missing","fetched_at":"2026-11-20 09:14:57","note":"no Erowid substance of that name"},{"source":"gsrs","status":"ok","fetched_at":"2026-11-20 09:14:58","note":null},{"source":"hmdb","status":"missing","fetched_at":"2026-11-20 09:14:57","note":"hmdb.ca refused automated access to HMDB0014846"},{"source":"kegg","status":"missing","fetched_at":"2026-11-20 09:15:00","note":"no KEGG DRUG entry"},{"source":"pubchem","status":"ok","fetched_at":"2026-11-20 09:14:56","note":null},{"source":"reddit","status":"missing","fetched_at":"2026-11-20 09:14:57","note":"no r/tripreports posts mention it"},{"source":"sider","status":"ok","fetched_at":"2026-11-20 09:14:57","note":null},{"source":"structure","status":"ok","fetched_at":"2026-11-20 09:14:57","note":null},{"source":"wikipedia","status":"ok","fetched_at":"2026-11-20 09:14:57","note":null}],"description":"Sufentanyl is a anaesthetic, opioid substance."}